UK markets closed

Dermapharm Holding SE (0A5J.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
54.09+0.14 (+0.26%)
At close: 06:18PM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.05
52-week change 38.42%
S&P500 52-week change 323.10%
52-week high 353.85
52-week low 334.40
50-day moving average 344.09
200-day moving average 342.00

Share statistics

Avg vol (3-month) 315.48k
Avg vol (10-day) 320.11k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 817.39M
% held by insiders 167.74%
% held by institutions 118.27%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.88
Trailing annual dividend yield 31.63%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 5.42%
Operating margin (ttm)24.74%

Management effectiveness

Return on assets (ttm)6.76%
Return on equity (ttm)11.24%

Income statement

Revenue (ttm)1.15B
Revenue per share (ttm)21.37
Quarterly revenue growth (yoy)-7.20%
Gross profit (ttm)N/A
EBITDA 220.3M
Net income avi to common (ttm)62.37M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)159.54M
Total cash per share (mrq)2.96
Total debt (mrq)1.08B
Total debt/equity (mrq)198.22%
Current ratio (mrq)1.60
Book value per share (mrq)10.02

Cash flow statement

Operating cash flow (ttm)219.42M
Levered free cash flow (ttm)106.43M